View Full Paper

Owner Consent Verified
Report 4.8

Tourism Recovery Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A Comparative Perspective

20
Pages
IEEE
Style
~ 21–30 mins
Reading Time
InsurTech NLP Education
Abstract

This report investigates “Tourism Recovery Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A Comparative Perspective” using a benchmarking and maturity modeling. Through a human-centered lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Download PDF Order Similar Paper Save

Tourism Recovery Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A Comparative Perspective

ABSTRACT
Tourism Recovery Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A Comparative Perspective is unpacked across themes: change enablement, KPIs, equity, and ethics. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
19 Pages 4.4
Resilience And Continuity in Sustainability for EU Startups: Post-Pandemic Lessons
Governance Green Finance InsurTech
View Paper
12 Pages 4.9
Platform Engineering Adoption in Hospitality Operators: Scaling And Replication — Evidence from Benelux
Governance Epidemiology Cloud
View Paper
26 Pages 4.8
Circular Economy and Interoperability among Urban Households — Post-Pandemic Lessons
CV RPA Education
View Paper